BARD ASSOCIATES INC - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 48 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARD ASSOCIATES INC ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$488,000
+8.9%
76,615
-0.6%
0.24%
+8.0%
Q1 2019$448,000
-8.9%
77,115
-1.3%
0.23%
-20.4%
Q4 2018$492,000
-78.2%
78,115
-80.3%
0.28%
+36.5%
Q3 2018$2,260,000
-7.4%
395,575
-0.6%
0.21%
-8.0%
Q2 2018$2,440,000
+338.8%
398,075
+378.4%
0.23%
-18.4%
Q1 2018$556,000
-13.9%
83,215
-4.4%
0.28%
-10.6%
Q4 2017$646,000
+3.5%
87,015
-1.5%
0.31%
+6.9%
Q3 2017$624,000
+0.6%
88,315
-0.2%
0.29%
+3.2%
Q2 2017$620,000
-79.8%
88,515
-80.0%
0.28%
-1.7%
Q1 2017$3,075,000
+504.1%
442,825
+378.7%
0.29%
+21.2%
Q4 2016$509,000
+8.1%
92,515
-1.6%
0.24%
+2.6%
Q3 2016$471,000
+11.1%
94,015
-0.3%
0.23%
+2.2%
Q2 2016$424,000
+0.5%
94,315
+0.4%
0.22%
-7.4%
Q1 2016$422,000
+1.9%
93,975
+19.5%
0.24%
-0.4%
Q4 2015$414,000
-11.5%
78,625
-3.0%
0.24%
-9.3%
Q3 2015$468,000
-20.7%
81,090
-1.7%
0.27%
-8.2%
Q2 2015$590,000
+1.9%
82,490
-5.1%
0.29%
+5.4%
Q1 2015$579,000
+9.0%
86,940
-2.0%
0.28%
+12.1%
Q4 2014$531,000
+20.4%
88,740
-0.7%
0.25%
+20.4%
Q3 2014$441,000
+9.7%
89,340
-0.1%
0.21%
+29.6%
Q2 2014$402,000
-2.2%
89,415
-2.1%
0.16%
-8.6%
Q1 2014$411,000
-10.7%
91,315
+1.5%
0.17%
-8.9%
Q4 2013$460,000
+11.1%
89,953
-1.5%
0.19%
+4.4%
Q3 2013$414,000
-12.7%
91,303
-1.7%
0.18%
-17.6%
Q2 2013$474,00092,8400.22%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$541,7780.01%
Renaissance Technologies 555,763$1,0500.00%
Oakworth Capital, Inc. 3,052$5,7680.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$3540.00%
MORGAN STANLEY 11,274$21,3080.00%
BlackRock Inc. 110,990$209,7710.00%
Bank of New York Mellon Corp 75,268$142,2560.00%
Citadel Advisors 32,400$61,2360.00%
Citadel Advisors 6,400$12,0960.00%
Citadel Advisors 5,933$11,2130.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders